503 related articles for article (PubMed ID: 16309894)
1. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Padurariu M; Ciobica A; Dobrin I; Stefanescu C
Neurosci Lett; 2010 Aug; 479(3):317-20. PubMed ID: 20561936
[TBL] [Abstract][Full Text] [Related]
3. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Pillai A; Parikh V; Terry AV; Mahadik SP
J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzyme and malondialdehyde levels in patients with social phobia.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
Psychiatry Res; 2008 May; 159(1-2):95-100. PubMed ID: 18339429
[TBL] [Abstract][Full Text] [Related]
5. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.
Evereklioglu C; Er H; Doganay S; Cekmen M; Turkoz Y; Otlu B; Ozerol E
Doc Ophthalmol; 2003 Mar; 106(2):129-36. PubMed ID: 12678277
[TBL] [Abstract][Full Text] [Related]
7. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.
Raffa M; Mechri A; Othman LB; Fendri C; Gaha L; Kerkeni A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1178-83. PubMed ID: 19576938
[TBL] [Abstract][Full Text] [Related]
8. Free radicals, antioxidant defense systems, and schizophrenia.
Wu JQ; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
10. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant defense in overt and subclinical hypothyroidism.
Reddy VS; Gouroju S; Suchitra MM; Suresh V; Sachan A; Srinivasa Rao PV; Bitla AR
Horm Metab Res; 2013 Sep; 45(10):754-8. PubMed ID: 23828125
[TBL] [Abstract][Full Text] [Related]
12. Free radicals in patients with post-traumatic stress disorder.
Tezcan E; Atmaca M; Kuloglu M; Ustundag B
Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):89-91. PubMed ID: 12799747
[TBL] [Abstract][Full Text] [Related]
13. Markers of antioxidant defence system and lipid peroxidation in peripheral blood of female patients with chronic idiopathic urticaria.
Kasperska-Zajac A; Brzoza Z; Polaniak R; Rogala B; Birkner E
Arch Dermatol Res; 2007 Mar; 298(10):499-503. PubMed ID: 17171548
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia.
Herken H; Uz E; Ozyurt H; Söğüt S; Virit O; Akyol O
Mol Psychiatry; 2001 Jan; 6(1):66-73. PubMed ID: 11244487
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
16. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy--induced hypertension.
Krishna Mohan S; Venkataramana G
Indian J Physiol Pharmacol; 2007; 51(3):284-8. PubMed ID: 18341226
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.
Dakhale G; Khanzode S; Khanzode S; Saoji A; Khobragade L; Turankar A
Neuropsychobiology; 2004; 49(4):205-9. PubMed ID: 15154399
[TBL] [Abstract][Full Text] [Related]
18. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.
Yao JK; Reddy R; McElhinny LG; van Kammen DP
J Psychiatr Res; 1998; 32(6):385-91. PubMed ID: 9844955
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder.
Kuloglu M; Atmaca M; Tezcan E; Ustundag B; Bulut S
Neuropsychobiology; 2002; 46(4):186-9. PubMed ID: 12566935
[TBL] [Abstract][Full Text] [Related]
20. Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children.
László A; Novák Z; Szőllősi-Varga I; Hai du Q; Vetró Á; Kovács A
Ideggyogy Sz; 2013 Jan; 66(1-2):23-8. PubMed ID: 23607226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
